Crossmark

Review of the European Union Clinical Trials Regulation: Key Early Learnings from the United Kingdom Drug Information Association Medical Writing Committee

Crossref DOI link: https://doi.org/10.1007/s43441-024-00726-2

Published Online: 2024-11-28

Published Print: 2025-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Koo, Dicken D. H.

Taylor, Eve

Hooper, Iain T.

Khaled, Saman F.

Fagan, Vivien

Turner, Helen

Buttery, Harriet L.
License Information

Text and Data Mining valid from 2024-11-28

Version of Record valid from 2024-11-28
More Information

Article History

Received: 23 April 2024

Accepted: 15 November 2024

First Online: 28 November 2024

Declarations

:

: The authors declare no competing interests. The opinions provided in this manuscript represent the collective views of the UK DIA MW Committee, and do not reflect the views of the individual organizations represented by any of the authors on this manuscript.

Document is current

Any future updates will be listed below